Comparison of granisetron and the combination of granisetron plus methylprednisolone in the prophylaxis of cisplatin-induced emesis

International Journal of Clinical Oncology

Volumn 2, Issue 3, 1997, Pages 138-142

  Nakanishi, Masaki ^a   Ohsawa, Jirou ^a   Nonaka, Masahiko ^a   Kamiyama, Jun ^a   Idoguchi, Kohji ^a   Tabata, Takahisa ^a   Okuno, Tomoko ^a   Shinoda, Masaaki ^a  

^a ASAHI UNIVERSITY   (Japan)

Author keywords

Antiemetic supportive therapy; Cisplatin induced emesis; Granisetron; Methylprednisolone

Indexed keywords

EID: 27844472278     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02490123     Document Type: Article

References (14)

1. Kris MG, Gralla RJ, Clark RA, Tyson L, O'Connell J, Werthein M, Kelsen D. Incidence, course and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 1985;3:1379-1384.
2. Chevallier M, and the Granisetron Study Group. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose in a single-blind study. Eur J Cancer 1990;26 (suppl 1):S33-S36.
3. 3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. Eur J Cancer 1990;26 (suppl 1):S28-S32
4. Marry M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, PuJade-Lauraine E, Paule B, Paes D, Bons J. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990;322:816-821.
5. Tonato M, and the Italian Oncological Group for Clinical Research. Ondansetron plus dexamethasone: an effective combination in high-dose cisplatin therapy. Eur J Cancer 1991;27(suppl 1):S12-S14.
6. Smith DB, Newlands ES, Rustin GJS, Begent RHJ, Howells N, McQuade B, Begshawe KD. Comparison of ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991;338:487-490.
7. Carmichael J, Bessel EM, Harris AL, Hutcheon AW, Dawer PJDK, Daniels S. Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis. Br J Cancer 1994;70:1161-1164.
8. Moreno I, Rosell A, Abad-Esteve A, Barnadas A, Carles J, Ribelles N. Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Oncology 1991;48:397-402
9. Kris M, Gralla R, Tyson L, Clark R, Relsen D, Reilly L, Groshen S, Bosl G, Kalman L. Improved control of cisplatin-induced emesis with high-dose metoclopramide and combination of metoclopramide, dexamethasone and diphenhydramine: results of consecutive trials in 255 patients. Cancer 1985; 55:527-534.
10. Rosel R, Abad-Esteve A, Ribas M, Moreno L. Evaluation of combination antiemetic regimen including iv high-dose metoclopramide, dexamethasone and diphenyldramine in cisplatin based chemotherapy regimens. Cancer Treat Rep 1985;69:909-910.
11. Tabona MV. An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy. Eur J Cancer 1990;26(suppl 1):S33-S41.
12. Kris M, Gralla R, Tyson L, Clark R, Cirrincione C, Groshen S. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 1989;7:108-114.
13. Grunberg SM, Grosen S, Stevenson LL, McDermid J, Lucci L, Sanderson P E. Double- blind randomized study of 2 doses of oral ondansetron (GR 38032F) for the prevention of cisplatin (C)-induced delayed nausea (N) and vomiting (V). Proc Am Soc Clin Oncol 1990;9:327 (Abstr).
14. Lee BJ. Methylprednisolone as an antiemetic. N Engl J Med 1981;304:486.